229 related articles for article (PubMed ID: 21406335)
41. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
Yuki A; Shinkuma S; Hayashi R; Fujikawa H; Kato T; Homma E; Hamade Y; Onodera O; Matsuoka M; Shimizu H; Iwata H; Abe R
J Am Acad Dermatol; 2018 Dec; 79(6):1039-1046. PubMed ID: 29928911
[TBL] [Abstract][Full Text] [Related]
42. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
[TBL] [Abstract][Full Text] [Related]
43. The molecular pathogenesis of mycosis fungoides and Sézary syndrome.
Döbbeling U
G Ital Dermatol Venereol; 2008 Dec; 143(6):385-94. PubMed ID: 19169211
[TBL] [Abstract][Full Text] [Related]
44. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
45. Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis.
Huang Y; Litvinov IV; Wang Y; Su MW; Tu P; Jiang X; Kupper TS; Dutz JP; Sasseville D; Zhou Y
Oncotarget; 2014 Jun; 5(12):4418-25. PubMed ID: 24947046
[TBL] [Abstract][Full Text] [Related]
46. Assessment of Tissue Level of Histone Deactylase-2 (HDAC-2) in Patients With Mycosis Fungoides.
El Tawdy A; Amin I; Abdel Hay R; Rashed L; Gad Z
J Cutan Med Surg; 2016 Jan; 20(1):40-3. PubMed ID: 26033703
[TBL] [Abstract][Full Text] [Related]
47. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
Fivenson DP; Hanson CA; Nickoloff BJ
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
[TBL] [Abstract][Full Text] [Related]
48. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
49. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.
Hahtola S; Tuomela S; Elo L; Häkkinen T; Karenko L; Nedoszytko B; Heikkilä H; Saarialho-Kere U; Roszkiewicz J; Aittokallio T; Lahesmaa R; Ranki A
Clin Cancer Res; 2006 Aug; 12(16):4812-21. PubMed ID: 16914566
[TBL] [Abstract][Full Text] [Related]
50. [Screening of differentially expressed microRNAs in borderline and malignant gastrointestinal stromal tumors].
Shi Y; Wang CZ; Hou YY; He DM; Xu C; Liu YL; Hu Q; Akesu S; Zeng HY; Shen KT; Tan YS; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):20-5. PubMed ID: 23611268
[TBL] [Abstract][Full Text] [Related]
51. Altered microRNA expression in mycosis fungoides.
Maj J; Jankowska-Konsur A; Sadakierska-Chudy A; Noga L; Reich A
Br J Dermatol; 2012 Feb; 166(2):331-6. PubMed ID: 21966986
[TBL] [Abstract][Full Text] [Related]
52. MicroRNAs and their signaling pathway in mycosis fungoides.
Sun Z; Yao X; Ding X; Li X; Tian X
Medicine (Baltimore); 2022 Jun; 101(25):e29248. PubMed ID: 35758353
[TBL] [Abstract][Full Text] [Related]
53. Histopathologic-molecular correlation in early mycosis fungoides using T-cell receptor gamma gene rearrangement by polymerase chain reaction with laser capture microdissection.
Hsiao PF; Hsiao CH; Lin YC; Tseng MP; Tsai TF; Jee SH
J Formos Med Assoc; 2007 Apr; 106(4):265-72. PubMed ID: 17475602
[TBL] [Abstract][Full Text] [Related]
54. From Benign Inflammatory Dermatosis to Cutaneous Lymphoma. DNA Copy Number Imbalances in Mycosis Fungoides versus Large Plaque Parapsoriasis.
Gug G; Solovan C
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34063545
[No Abstract] [Full Text] [Related]
55. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
57. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
58. Mycosis fungoides-derived exosomes promote cell motility and are enriched with microRNA-155 and microRNA-1246, and their plasma-cell-free expression may serve as a potential biomarker for disease burden.
Moyal L; Arkin C; Gorovitz-Haris B; Querfeld C; Rosen S; Knaneh J; Amitay-Laish I; Prag-Naveh H; Jacob-Hirsch J; Hodak E
Br J Dermatol; 2021 Nov; 185(5):999-1012. PubMed ID: 34053079
[TBL] [Abstract][Full Text] [Related]
59. Circular RNA expression in cutaneous squamous cell carcinoma.
Sand M; Bechara FG; Gambichler T; Sand D; Bromba M; Hahn SA; Stockfleth E; Hessam S
J Dermatol Sci; 2016 Sep; 83(3):210-8. PubMed ID: 27298156
[TBL] [Abstract][Full Text] [Related]
60. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
Manfè V; Biskup E; Rosbjerg A; Kamstrup M; Skov AG; Lerche CM; Lauenborg BT; Odum N; Gniadecki R
PLoS One; 2012; 7(1):e29541. PubMed ID: 22235305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
